These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13246580)

  • 1. [Preliminary note on the first results of bone marrow in large doses in disorders of bleeding time and of coagulation time].
    TREMBLAY EC
    Sang; 1955; 26(4):438-41. PubMed ID: 13246580
    [No Abstract]   [Full Text] [Related]  

  • 2. [COMPARATIVE STUDY OF THE COAGULATION FACTORS OF THE BONE MARROW AND BLOOD].
    POPPA C; POPA L; ENACHE F; NICOARA S
    Stud Cercet Med Interna; 1963; 123():837-46. PubMed ID: 14107491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hemorrhagic diathesis with bone marrow transplantation with reference to methods and indications].
    MIGDALSKA-ROMANIUK Z
    Pol Arch Med Wewn; 1955; 25(1a):157-65. PubMed ID: 14394913
    [No Abstract]   [Full Text] [Related]  

  • 4. [BLEEDING TIME].
    CAEN J
    Hemostase; 1964; 4():203-13. PubMed ID: 14220199
    [No Abstract]   [Full Text] [Related]  

  • 5. The bone marrow in hemophilia during life; a study of the cellular elements and the coagulation time of the marrow blood.
    LIMARZI LR; PONCHER HG; BIRCH CL
    J Lab Clin Med; 1946 Jul; 31(7):777-84. PubMed ID: 20992881
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDIES ON COAGULATION AND HEMOSTASIS IN POLYCYTHEMIA VERA. ITS RELATIONSHIP TO ERYTHROKINESIS].
    KLEIMANS M; CARMENA AO; BARRAZA O; SEGADE A; DEHUBERMAN AS
    Sangre (Barc); 1963; 13():160-8. PubMed ID: 14106456
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudohemophilia type B; hereditary hemorrhagic diathesis characterized by prolonged bleeding time and decrease in antihemophilic factor.
    SINGER K; RAMOT B
    AMA Arch Intern Med; 1956 Jun; 97(6):715-25. PubMed ID: 13312713
    [No Abstract]   [Full Text] [Related]  

  • 8. [The medullary antianemic and antihemogenic factor].
    DESMONTS T
    Rev Pathol Gen Physiol Clin; 1962 Feb; 62():237-40. PubMed ID: 13885744
    [No Abstract]   [Full Text] [Related]  

  • 9. [Children with hemorrhagic diathesis: correct diagnostic and therapeutic approach].
    Carnelli V; Dozzi M; Gibelli M; Giovanniello A; Riva F; Seidita C; Stucchi C
    Pediatr Med Chir; 1990; 12(1):1-13. PubMed ID: 2198546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood transfusion as substitution therapy in factor V- and factor VII deficiency].
    THIES HA; BOECKER D
    Munch Med Wochenschr; 1955 Dec; 97(51):1717-8. PubMed ID: 13288517
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rational diagnosis of hemorrhagic diathesis as a basis for quick therapeutic treatment].
    Remde W
    Z Arztl Fortbild (Jena); 1966 Sep; 60(17):1002-6. PubMed ID: 5995284
    [No Abstract]   [Full Text] [Related]  

  • 12. [Schedule for diagnostic-therapeutic management of hemorrhagic diathesis].
    Sulek K
    Wiad Lek; 1973 Mar; 26(5):417-22. PubMed ID: 4570815
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and therapy of hemostatic disorders in oncology. A short review].
    Rasche H
    Onkologie; 1984 Feb; 7 Suppl 1():28-30. PubMed ID: 6371638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [First results of the treatment of chronic evolutive polyarthritis by high-doses of bone marrow].
    TREMBLAY EC; DURIEU J
    Rev Rhum Mal Osteoartic; 1954; 21(9-10):690-2. PubMed ID: 13225381
    [No Abstract]   [Full Text] [Related]  

  • 15. [Latent hemorrhagic diathesis as cause of gynecologic hemorrhages].
    Schwenke H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(1):74-80. PubMed ID: 4165543
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful treatment of massive hemorrhagic diathesis caused by Factor VIII:C-antibodies with adsorption plasmapheresis and immunosuppression].
    Mondorf W; Grützmacher P; Schmidt H; Wolff B; Scharrer I; von Baum H
    Med Klin (Munich); 1991 Mar; 86(3):165-70, 171. PubMed ID: 1903498
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities in the treatment of hemorrhagic diathesis in bone-marrow insufficiency].
    Gehrmann G
    Hamatol Bluttransfus; 1975; 16():295-305. PubMed ID: 1193447
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleeding diathesis coincident with chronic myelomonocytic leukaemia.
    Heard SE; Revell P; Holland LJ; Hurdle AD; Savidge GF
    J Clin Pathol; 1991 Nov; 44(11):956-8. PubMed ID: 1752989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoprecipitate shortens the bleeding time and reduces bleeding complications in patients with uremia.
    Jubelirer SJ; Janson PA; Weinstein MJ; Deykin D
    Trans Assoc Am Physicians; 1980; 93():182-91. PubMed ID: 6787774
    [No Abstract]   [Full Text] [Related]  

  • 20. Congenital hemorrhagic diathesis with deficiency of factor XIII. A case report and a family study.
    Abels J; Sibinga CT; Meyler L
    Thromb Diath Haemorrh; 1970 May; 23(2):340-6. PubMed ID: 5426214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.